Elsevier, The Lancet, Volume 398, 6 November 2021
The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world
Elsevier, The Lancet Digital Health, Volume 3, April 2021
Data-driven digital health technologies have the power to transform health care. If these tools could be sustainably delivered at scale, they might have the potential to provide everyone, everywhere, with equitable access to expert-level care, narrowing the global health and wellbeing gap. Conversely, it is highly possible that these transformative technologies could exacerbate existing health-care inequalities instead.
Elsevier, Smart Health, Volume 9-10, December 2018
This work intends to develop an intelligent, four-dimensional (namely X-Y-Z plus somatosensory), partial control, and virtual-reality-enabled Tai-Chi System (VTCS). Tai-Chi is a traditional mind-body wellness and healing art, and its clinical benefits have been well documented. VTCS integrates Tai-Chi with a series of cutting-edge computer technologies including 4D sensor technology, big-data, signal processing and analysis, human body kinematics, deep learning, virtual reality, and 4D-reconstruction, etc.
Elsevier, Drug Discovery Today, Volume 22, 1 February 2017
The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts
Anti-infective drugs have had a key role in the contemporary world, contributing to dramatically decrease mortality rates caused by infectious diseases worldwide. Antimicrobial peptides (AMPs) are multifunctional effectors of the innate immune system of mucosal surfaces and present antimicrobial activity against a range of pathogenic viruses, bacteria, and fungi. However, the discovery and development of new antibacterial drugs is a crucial step to overcome the great challenge posed by the emergence of antibiotic resistance.